Michel van Gelder

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

Monique Terwijn, Wim L.J. van Putten, Angèle Kelder et al. · Journal of Clinical Oncology · 2013 · 444 citations · Full text

Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells

Subhashis Sarkar, Wilfred T.V. Germeraad, Kasper M.A. Rouschop et al. · PLoS ONE · 2013 · 208 citations · Full text

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina et al. · Blood Advances · 2022 · 105 citations · Full text

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

Michel van Gelder, Liesbeth C. de Wreede, Martin Bornhäuser et al. · Bone Marrow Transplantation · 2016 · 71 citations · Full text

Transplantation, Marrow Transplantation, Immunology +8